Gloria F. Basse - 11 Jun 2025 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)

Role
Director
Signature
/s/ Michael F Brigham Attorney-in-Fact
Issuer symbol
ICCC
Transactions as of
11 Jun 2025
Net transactions value
+$16,979
Form type
4
Filing time
13 Jun 2025, 13:05:35 UTC
Previous filing
24 Sep 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Basse Gloria F Director C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND /s/ Michael F Brigham Attorney-in-Fact 13 Jun 2025 0001869527

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICCC Common stock $0.10 per value per share Options Exercise $16,979 +3,530 $4.81 3,530 11 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICCC Non Qualified Stock Options (Right to buy) Options Exercise $0 -11,470 -76% $0.000000 3,530 11 Jun 2025 Common Stock 11,470 $4.81 Direct F2
transaction ICCC Non Qualified Stock Options (Right to buy) Options Exercise $0 -4 -100% $0.000000 0 11 Jun 2025 Common Stock 3,530 $4.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) Shares acquired in stock option net exercise transaction with the Issuer.
F2 (2) Original stock option was for 15,000 shares. These shares resulted from a net exercise transaction, with 11,470 shares withheld (credited at $6.29 per share, the closing price of the Common stock on the date of exercise) in payment of the exercise price for 3,530 shares.